Needham maintains EverQuote at Buy, raises price target to $35 from $30

Needham reaffirmed its Buy rating for EverQuote and increased its price target to $35 from $30, suggesting a 44.2% upside from the Nov 2 close of $24.27, according to the firm.

Original reporting
Published Nov 3, 2026, 1:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 1:57 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Needham maintains EverQuote at Buy, raises price target to $35 from $30 — source image
Decision brief

The 30-second read

Med
01

Why it matters

The price target increase signals confidence in growth prospects, likely prompting short-term buying.

02

Market read

Analyst target raise provides a fresh catalyst for EverQuote, potentially driving price appreciation.

03

What to watch

Potential competitive pressure from larger insurers could temper upside.

Relevance 6/10Novelty 6/10Timing: immediate

Background

EverQuote is a digital insurance marketplace; analyst coverage influences its valuation.

Market effects

May lift sentiment in the online insurance brokerage sector.

Limited to U.S. equity markets where EverQuote trades.

Minimal global impact beyond sector peers.

Counterpoint

Target raises can be premature if earnings miss expectations.

Key entities

  • Needham

    Equity research firm that issued the rating upgrade.

  • EverQuote

    Online insurance marketplace (NASDAQ: EVR).

Related articles

$EVERHigh

EverQuote (EVER) Stock Price Jumps As Q3 Earnings Back Growth

EverQuote (EVER) reported Q3 adjusted EBITDA margin of 16.3% and VMM of 28.7%, with Q4 guidance indicating a sequential VMM decline. The company is investing in agentic and LLM channels, which may compress margins in the near term. The article also highlights three other companies potentially undervalued by 30-35% according to the author's estimates.

$EVERMed

EverQuote: Q3 Earnings Snapshot

EverQuote reported Q3 net income of $18.2M, or 49 cents per share, with adjusted EPS of 72 cents. Revenue was $218.1M, exceeding analysts' estimates. The company expects Q4 revenue between $213M and $223M, according to Zacks Investment Research.